NBSE
NeuBase Therapeutics, Inc. Common Stock
NBSE
NBSE
Delisted
NBSE was delisted on the 10th of May, 2024.
47 hedge funds and large institutions have $9.59M invested in NeuBase Therapeutics, Inc. Common Stock in 2015 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 14 increasing their positions, 15 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
95% less call options, than puts
Call options by funds: $50K | Put options by funds: $1.06M
Holders
47
Holding in Top 10
–
Calls
$50K
Puts
$1.06M
Top Buyers
| 1 | +$1.03M | |
| 2 | +$402K | |
| 3 | +$301K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$111K |
| 5 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$106K |
Top Sellers
| 1 | -$4.46M | |
| 2 | -$1.34M | |
| 3 | -$1.01M | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$457K |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
-$226K |